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Abstract
Background Psoriasis is an incurable and chronic disease
that includes unpredictable periods of remission and relapse
requiring long-term therapy.
Purpose This paper focuses on the relationship among
family coping, psychological morbidity, body image,
dyadic adjustment and quality of life in psoriatic patients
and their partners.
Method One hundred and one patients with psoriasis and
78 partners comprised the sample. They were regular users
of the Dermatology Service of a Central Northern hospital
in Portugal and a private dermatology clinic. Patients with
psoriasis were assessed on anxiety, depression, body image,
quality of life, dyadic adjustment and family coping.
Partners were assessed on the same measures except body
image and quality of life.
Results A positive relationship among dyadic adjustment,
psychological morbidity and family coping in patients and
their partners was found. Also, patients with lower levels of
quality of life had partners with higher levels of depressive
and anxious symptoms. Better dyadic adjustment predicted
family coping in the psoriatic patient. High levels of dyadic
adjustment in patients and low partners’ trait anxiety
predicted better dyadic adjustment in partners.
Conclusion The results highlight the importance of incor-
porating family variables in psychological interventions in
psoriasis’ care, particularly family coping and dyadic
adjustment as well as the need for psychological interven-
tion to focus both on patients and partners.
Keywords Psoriasis . Patients . Partners
Introduction
Psoriasis is an incurable and chronic disease that affects
approximately 2% of the world’s population. The disease
includes unpredictable periods of remission and relapse
requiring long-term therapy and can develop at any age [1].
In the Iberian Peninsula, it is more prevalent in men and
begins before age 30 in 65% of the cases [2].
The pathophysiology of psoriasis is complex, involving
components of the innate and adaptive immune systems,
genetics and environment (stress, skin injury, medication,
climate, alcohol and infection). This interplay of factors
results in an increase in antigen presentation and the
activation of T helper cell type 1 and T helper cell type
17, responsible for cutaneous plaques of psoriasis [3, 4].
Zachariae and colleagues [5] reported that patients with
psoriasis have 40–90% more psychological morbidity than
the general population. Several studies have shown that
40% of the psoriatic patients present with high levels of
anxiety [6], 10% present with clinical levels of depression
[7], 38% present with pathological levels of worrying [8]
and 10% present with suicidal ideation [9].
Ginsburg and Link [10] suggested that older age at
onset of psoriasis and gender (male) were associated with
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lower psychosocial morbidity. Patients who were older at
the time of onset of their psoriasis reported being less
sensitive to others’ opinions, had a lesser tendency to
anticipate rejection in social situations, were less secretive
and had fewer feelings of guilt and shame in relationship
to their psoriasis. Sampogna et al. [11] found the
prevalence of psychiatric morbidity to be higher in women
than men. Kossakowska et al. [12] found gender and age
onset to be the main contributors to negative emotional
control. In fact, adjusting to psoriasis later in life may be
more difficult than in earlier years when a patient is young
and has a lot of time to deal with negative emotions,
especially anger. However, Gupta et al. [13] found patients
with early onset (younger than 40 years) presenting with
greater psychopathology, probably as a result of greater
genetic susceptibility and experiencing more severe and
recurrent psoriasis.
The burden of psoriasis is substantial, with an impact on
quality of life comparable with that observed in major
chronic diseases such as cancer, arthritis and depression
[14]. Psoriasis negatively impacts physical, emotional,
social, sexual, professional and financial well-being [15–
18]. In fact, psoriasis causes problems in various dimen-
sions of health-related quality of life including daily
activities, leisure, work/school and personal relationships
[19]. Psoriatic patients’ quality of life was found to be
influenced more by the experienced stigma than the
severity of the disorder.
Krueger and colleagues [20] suggested that the severity
of psoriasis is mainly a quality of life issue. The two main
contributors to stress in patients with psoriasis are engaging
in avoidance behaviour and the belief that others evaluate
them on the basis of their skin disease. However, there is no
significant relationship between either physical severity or
anatomic location of psoriasis and psychological disability.
Therefore, severity of psoriasis is a composite of physical
and psychological factors [6].
Stigmatization is a central experience of psoriasis that
has a broad psychic and social impact. As might be
expected, patients with skin disorders may experience
social rejection, avoiding touch and fearing contagion or
filth. Such experiences devastate patients’ quality of life
[21] and are associated with significant levels of social
embarrassment, life disruption and social withdrawal [22].
In fact, distorted body image in psoriasis is associated with
problems in self-perception as a desirable sexual being and
disrupted intimate relationships [23].
Dyadic adjustment is also affected in psoriatic patients.
Frangos and Kimball [24] found the rate of divorce in
patients with psoriasis to be 11% and the negative impact on
relationships to be similar to that of other chronic conditions.
Koo [25] also found psoriasis to be a major obstacle in
creating and sustaining intimate relationships. Depression,
anxiety, coping and acrimonious disputes mediate the impact
of psoriasis on dyadic adjustment [26]. Richards et al. [27]
studied the psychological impact of psoriasis in healthy
partners and found significant correlations between patient
and partner levels of anxiety and depression. Gupta and
Gupta [28] found that 40% of psoriatic patients experience a
decrease in initiating or being receptive to sexual intimacy or
report having sexual problems related to their psoriasis [29].
Just as negative interactions may adversely affect marital
well-being, positive interactions between the patient and his/
her partner significantly improve coping strategies aimed at
outbreaks of psoriasis [30, 31]. Partners who show uncondi-
tional acceptance, demonstrate respect and sensitivity, use
humour and help the patient feel valued and attractive have
an ameliorating effect on marital well-being [32].
In Portugal, there are no studies on psoriatic patients and
their partners. In order to guide interventions that promote
quality of life and facilitate a better understanding of
couples’ coping strategies, this study focuses on the key
variables associated with outbreaks of psoriasis. In this
paper, five research questions were examined: First, how
are dyadic adjustment, psychological morbidity and family
coping in patients related to the same variables in their
partners? Second, what are the correlations between quality
of life in patients and psychological morbidity in their
partners? Third, what are the predictors of family coping in
patients? Fourth, what are the predictors of dyadic
adjustment in partners? Finally, what is the influence of
age onset and perception of illness severity on patient’s
psychological variables?
Based on the literature, the authors expected to find a
positive relationship between patients and partners’ varia-
bles and a negative relationship between quality of life in
patients and psychological morbidity in partners. The
authors also expected severity of psoriasis, psychological
morbidity, body image and dyadic adjustment to predict
family coping in patients. Finally, it is expected that
psychological morbidity and body image in patients
negatively predict dyadic adjustment in partners.
Method
Procedure
The sample consisted of all psoriatic patients seen by
four physicians who practiced in two locations (i.e.
Dermatology Service of a Central Northern Hospital
and an associated private clinic) over a 2-year period.
These physicians were responsible for all psoriatic
patients seen in the hospital and clinic. Patients were
invited by their physicians to participate. Patients were
free to decline participation and only those who showed
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an interest were contacted by the researcher. In order to
participate, all patients and partners completed consent forms
that outlined the study procedures.
After receiving the list of prospective patients, a research
assistant contacted their partners and explained the study.
Partners were instructed to come to the next regularly
scheduled patient appointment. Initially, 120 patients and
partners were contacted but only 101 patients and 78
partners filled out the consent forms.
Patients and their partners completed questionnaires in
separate rooms. Not all patients had partners, therefore
there is a significant difference in the number of partners
and patients. In addition, partners with psoriasis were
excluded from the study.
Sample Characteristics
The psoriatic patient sample (n=101) was equally split
between men and women (50.5% male and 49.5% female).
Similarly, partners (n=78) were also equally split (47.4%
male and 52.6% female). Mean age was for patients
43.9 years (s.d.=14.3) and 45.7 years (s.d.=14.15) for
partners. Nearly half of patients (45.5%) finished the sixth
grade, 17% finished the ninth grade, 19.5% completed
secondary education and, finally, 18% finished college.
Partners had roughly the same distribution: 50% had
4–6 years of education, 24.4% had between a seventh-
and ninth-grade education, and finally, 10% finished
graduate school. On average, patients were diagnosed with
psoriasis at age 24 (s.d.=12.6). Age of onset was grouped
according to following ranges: before age 15 (22.8%), be-
tween 16 and 30 years old (49.5%) and above 31 years old
(27.7%). Severity of psoriasis was categorized, according to
patients and partners’ perception, as mild (patients=16.8%,
partners=12.8%), moderate (patients=50.5%, partners=
57.7%) and severe (patients=32.7%, partners=29.5%).
Instruments
Patients completed the following questionnaires: Hospital
Anxiety and Depression Scale (HADS), Body Image Scale
(BIS), Psoriasis Disability Index (PDI), Dyadic Adjustment
Scale (R-DAS) and Family Crisis-Oriented Personal Evalua-
tion Scale (F-COPES). Instruments for partners were State-
Trait Anxiety Inventory (STAI), Beck Depression Inventory
(BDI), R-DAS and F-COPES.
All the instruments were adapted to the Portuguese
sample. The procedure followed Bradley’s orientation [33],
which includes translation to Portuguese by a bilingual
person, followed by a translation back to English, comparison
between the two versions, adaptation of specific terms by a
physician, pre-test of the research version to assess compre-
hension of items in a sample of 12 patients and, finally,
elaboration of the Portuguese version. Psychometric proper-
ties for all adapted instruments, including Cronbach’s alphas,
are presented below.
Psoriasis Disability Index PDI measures the quality of
life in patients with psoriasis. It was originally described
in 1985 [34, 35]. PDI consists of questions related to daily
activities, work or school, personal relationships, leisure
and treatment. PDI was constructed as a series of 10
questions [34] scored on a visual analogue scale of 1–7,
thus producing a score range of 10–70, and was later
revised in 1990 with a 15-question 4-point Likert scale
[36]. The scale has a range from 0 to 3, with items “not at
all” scoring “0” and “very much” scoring “3”. The
Portuguese version of the measure has not been normed
and has no clinical cut-off scores. PDI total scores range
from 0 to 45 with higher scores indicating a greater
impairment in a patient’s quality of life.
Although a persuasive case can be made for the overall
validity of the Portuguese adaptation of the scale, the subscales
of the original scale did not hold true. In the exploratory factor
analysis, the factors seen in the American instrument were not
replicated. To better understand this measure, the authors
followed the lead of Kent and Al-Abadie [37], who
performed a two-factor solution. The resulting adaptation
explained 57% of the total variance. One factor relates to
aspects of everyday activities (items 1, 2, 3, 4, 5 and 15) and
the second factor measures relationships with others (items 6,
7, 8, 9, 10, 11, 12, 13 and 14). The first factor (“everyday
activities”) explained 44% of the total variance while the
second factor (“relationship with others”) explained 13% of
the total variance. The overall instrument showed high
reliability—0.90—with both factors showing good reliabil-
ities: everyday activities (alpha=0.83) and relationship with
others (alpha=0.90) [38]. In this study, psoriatic patients’
mean score was 11.12 (s.d.=9.72). Although precise inter-
pretation is not possible, it appears that patients were
experiencing a moderate impairment in their quality of life.
Revised Dyadic Adjustment Scale R-DAS is a modifica-
tion of the original dyadic adjustment scale developed by
Spanier [39] and measures the strength of relationships
[40]. R-DAS has been shown to distinguish between
distressed and nondistressed samples with an overall
Cronbach’s alpha of 0.90 (total scale) and alphas of 0.81,
0.85 and 0.80 for consensus, satisfaction and cohesion
subscales, respectively [41]. R-DAS is composed of 14
items. In dyadic consensus, the scale ranges from 5
(“always in agreement”) to 0 (“always in disagreement”).
In dyadic satisfaction, the scale ranges from 0 (“never”) to
5 (“always”) and the cohesion scale ranges from 0
(“never”) to 4 (“every day”) in the first item and from 0
(“never”) to 5 (“frequent”) in the remaining three items.
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Higher scores reflect better perceptions of the quality of
the dyadic relationship.
The Portuguese adaptation of R-DAS [42] used 13
items for patients and 14 for partners. For patients,
Cronbach’s alpha was 0.90 for the overall R-DAS and
0.92 for consensus, 0.87 for satisfaction, and 0.67 for
cohesion. For partners, the alpha was 0.90 for the overall
R-DAS and 0.92 for consensus, 0.84 for satisfaction, and
0.73 for cohesion. In psoriatic patients, the three factors
explained 69.9% of the variance and 69.5% in partners.
The mean score for psoriatic patients was 48.4 (s.d.=11.5),
and the partners’ mean was 50.1 (s.d.=12.5).
Body Image Scale The BIS was created in collaboration
with the European Organization for Research and Treatment
in Cancer and was tested in a heterogeneous sample of 276
British cancer patients [43]. Following revisions, the scale
underwent psychometric testing with a sample of 682
patients with breast cancer, using datasets from seven UK
treatment trials/clinical studies. The scale showed high
reliability: Cronbach’s alpha was 0.93. A factor analysis
resulted in a single-factor solution that accounted for more
than 50% of the variability. Higher scores indicate dis-
satisfaction with body image.
The Portuguese-adapted version [44] for patients with
psoriasis showed a reliability of 0.93. Factor analysis
resulted in a single-factor solution accounting for greater
than 50% of the variance. The mean score for psoriatic
patients was 10.5 (s.d.=7.8).
State-Trait Anxiety Inventory Form Y STAI measures
anxiety in adults [45]. It clearly differentiates between the
temporary condition of “state anxiety” and the more general
and long-standing quality of “trait anxiety”. State anxiety
items are 1, 2, 5, 8, 10, 11, 15, 16, 19 and 20, and trait
anxiety items are 21, 23, 26, 27, 30, 33, 34, 36 and 39.
The Portuguese-adapted version [46] included 5,000
individuals in a normative sample and found alphas of 0.92
for state anxiety and 0.90 for trait anxiety. In partners, alpha
was 0.96 for state anxiety and 0.94 for trait anxiety.
Partners’ means were 41.81 (s.d.=14.91) for state anxiety
and 40.55 (s.d.=12.99) for trait anxiety.
Beck Depression Inventory The BDI-II measures depression
in adults [46]. The BDI-II is a self-administered 21-item
self-report scale measuring symptoms of depression and
demonstrates high internal consistency, with alphas of 0.86
and 0.81 for psychiatric and non-psychiatric populations,
respectively [47]. For the general population, a score of 21 or
over reveals depression. For individuals who have been
clinically diagnosed, scores of 0–13 indicate minimal depres-
sion; 14–19, mild depression; 20–28, moderate depression
and 29–63, severe depression.
The Portuguese-adapted version has much the same
psychometric properties. In partners [48], Cronbach’s
alpha was 0.89. The mean score for partners was 8.85
(s.d.=7.62). Unfortunately, no studies to date have
established clinical cut-off scores for non-clinical Portu-
guese samples.
Hospital Anxiety and Depression Scale The HADS mea-
sures depression and anxiety in patients [49]. The HADS is
a brief, widely used instrument that measures psychological
distress. The scale consists of 14 questions—seven for
anxiety and seven for depression. Although the question-
naire was designed for hospital outpatients, it has also been
extensively used in primary care services. The scale is
sensitive to change both during the course of disease and in
response to medical and psychological interventions [50].
Scores of 11 or more, on either subscale, are indicative of
high psychological morbidity, while scores of 8–10 are
considered “borderline” and scores of 0–7 are considered
“normal”. Cronbach’s alpha was 0.93 for the anxiety
subscale and 0.90 for the depression subscale.
The Portuguese-adapted version [51] had similar
psychometric properties to the original one, with an
overall alpha of 0.91. The Anxiety factor showed an alpha
of 0.87 and accounted for 16.3% of the variance while the
depression factor showed an alpha of 0.91 and accounted
for 46.2% of the variance. The mean for psoriatic patients
was 7.57 (s.d.=5.63) for depression and 10.36 (s.d.=5.13)
for anxiety.
Family Crisis-Oriented Personal Evaluation Scale The F-
COPES measures coping strategies in times of stress
[52]. The F-COPES assesses behaviour and problem-solving
strategies used by families in problematic or difficult
situations. This instrument, scored from 1 to 5, contains
29 coping behaviour items over five subscales: reframing
(i.e. positively reframing events to make them more manage-
able), passive appraisal (i.e. minimization of the response
to problematic issues), acquiring social support (i.e.
assesses the nuclear family’s ability to use help from
relatives, friends, neighbours and extended family as
resources), seeking spiritual support (i.e. family’s ability
to use this kind of support as a resource) and mobilising
family to acquire and accept help from community
resources outside the nuclear/extended family or other
relatives). Higher scores represent a family’s greater use of
the respective strategy.
The Portuguese-adapted version has 29 items showing
good reliability [53] with all subscales presenting alphas
over 0.70 except passive appraisal which showed an alpha
of 0.55. In psoriatic patients, the alpha for the overall F-
COPES was 0.86 and was 0.70 for reframing, 0.52 for
passive appraisal, 0.80 for acquiring social support, 0.81
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for seeking spiritual support and 0.75 for mobilising
family to acquire and accept help. For partners, the alpha
for the overall F-COPES was 0.88, and was 0.66 for
reframing, 0.69 for passive appraisal, 0.83 for acquiring
social support, 0.84 for seeking spiritual support and 0.77
for mobilising family to acquire and accept help. Psoriatic
patients’ mean score was 97.4 (s.d.=15.97) while partners’
mean score was 94 (s.d.=17.9).
Data Analysis
First, Pearson correlations were obtained to identify relation-
ships between family and individual variables. Later, a
regression analysis was performed to determine the best
predictors of family coping and dyadic adjustment. Since the
goal was to assess the contribution of partners’ variables on
patients and the impact of patients’ psychological variables
after the contribution of socio-demographic/clinical variables,
the stepwisemethodwas selected. The only variables included
in the model were those that presented a significant correlation
with the dependent variable. A pairwise exclusion was
conducted to ensure that there would be an equal number
(n=78) for all analyses that included both patients and
partners. For analyses that involved just patients, the entire
sample of 101 was used.
Results
Influence of Severity of Psoriasis
Severity of psoriasis was categorized as mild, moderate or
severe according to patients’ perceptions. Results revealed
significant differences in anxiety, (χ2=7.307; p=.026),
quality of life (global and daily activities), (χ2=9.568; p=
0.017; χ2=8.171; p=0.008) and dyadic adjustment (global
and cohesion), (χ2=6.722; p=0.035; χ2=10.30; p=0.006).
In fact, psoriatic patients perceiving their illness as severe,
presented with more anxiety, worse quality of life (global
and daily activities) and lower dyadic adjustment (global
and cohesion) when compared with those exhibiting mild
or moderate severity (Table 1).
Influence of Age Onset
Age of onset was grouped according to the following
categories: before age 15, between 16 and 30 years old and
above 31 years old. Results revealed significant differences
in psychological morbidity. Patients whose illness devel-
oped between ages 16 and 30 presented with more
depressive symptoms (χ2=7.263; p=0.026) and anxiety
(χ2=8.622; p=0.013) (Table 2).
Predictors of Family Coping in Patients
Since sex, age at onset of psoriasis and perception of illness
severity were correlated with family coping, they were all
introduced in the first block, in the regression analysis.
Psychological variables pertaining to the patient that were
also correlated with patient’s family coping, i.e. body
image, psychological morbidity and dyadic adjustment,
were introduced in the second block. Although other
variables did not prove to be significant, patients’ dyadic
adjustment explained 13% of the variance (Table 3).
Family Coping, Dyadic Adjustment and Psychological
Morbidity in Patients and Partners
Dyadic adjustment was negatively correlated with psycho-
logical morbidity and family coping in patients. The same
result was found in partners.
Dyadic adjustment and family coping in partners were
negatively associated with psychological morbidity in
patients. However, family coping in partners was not
associated with depression in patients (Table 4).
Quality of Life in Psoriatic Patients Versus Psychological
Morbidity in Partners
Results showed a significant correlation between quality of
life (global, everyday activities and relationship with
others) in patients and psychological morbidity in partners.
Patients with low quality of life (globally, on everyday
activities and on relationship with others) had partners with
higher levels of psychological morbidity (Table 5).
Predictors of Dyadic Adjustment in Partners
Since the goal was to study the impact of patients’ variables
on partners’ dyadic adjustment, the variables were included
in two blocks. In the first block, patients’ psychological
morbidity, dyadic adjustment and body image were intro-
duced. In the second block, partners’ psychological
morbidity and family coping were added. Results showed
patients’ dyadic adjustment and partners’ trait anxiety to be
significant predictors, explaining 68.5% of the variance
(Table 6).
Discussion
Psoriatic patients with a severe perception of psoriasis
presented with more anxiety, worse quality of life (global
and on “everyday activities”) and lower dyadic adjustment
(global and dyadic cohesion) when compared to patients
who perceived themselves as having either mild or
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moderate severity. Scharloo and colleagues [54] concluded
that perceptions of psoriasis as a severe illness were
associated with a greater frequency of medical consulta-
tions and poorer quality of life in terms of physical health,
social functioning and mental health.
Skin plays an important role as an organ of communication
throughout life, greatly affecting an individual’s body image
and self-esteem [55]. It is a truism that adolescents and
young adults pride themselves on their appearance and have
more social contacts and relationships. This is supported by
the finding that patients whose illness developed between
age 16 and 30 presented with more depressive symptoms
and anxiety compared with other age groups. This finding is
in accordance with a study by Youn et al. [56] that revealed
psoriasis with an onset prior to age 40 to be associated with
more psychological stress compared with later onset. Gupta
et al. [13] found similar results.
Patients’ dyadic adjustment was the only variable that
predicted family coping in patients; interestingly, psycholog-
ical morbidity and body image did not. This result may be a
reflection of the quality of the relationship with the partner. In
fact, dyadic adjustment appears crucial among patients with
chronic conditions, since illness management is complex and
multifaceted. As a result, when the patient has a good dyadic
adjustment, the couple may be more motivated to utilize
family coping strategies and vice versa. In fact, psychological
morbidity and body image may not act as predictors, since
psychological morbidity in this sample was only moderate,
and the same holds true for dissatisfaction with body image
(below average) .
Table 1 Results of Kruskal-Wallis regarding dyadic adjustment, psychological morbidity, body image, quality of life and family coping in patients
according to perception of psoriasis’ clinical severity (N=101)
Dependent variables Perception of clinical severity (mean rank) χ2 p
Mild (n=17) Moderate (n=51) Severe (n=33)
HADS Depression 44.44 49.37 56.89 2.360 0.307
Anxiety 47 45.06 62.24 7.307 0.026*
BIS Body image 45.74 47.62 58.94 3.663 0.160
PDI Everyday activities 32.59 51.65 59.48 9.568 0.008**
Relationship with others 38.94 51.20 56.91 4.304 0.116
Global quality of life 34.29 51.23 59.26 8.171 0.017*
R-DAS Consensus 60.06 50.95 46.41 2.455 0.293
Satisfaction 58.09 48.32 51.48 1.483 0.477
Cohesion 69.53 50.91 41.59 10.301 0.006**
Global dyadic adjustment 66.68 50.21 44.15 6.722 0.035*
*p≤0.05; **p≤0.01
Table 2 Results of Kruskal-Wallis regarding dyadic adjustment, psychological morbidity, body image, quality of life and family coping in patients
according to age onset (N=101)
Dependent variables Age onset (mean rank) χ2 p
<15 years (n=23) 16–30 years (n=50) >31 years (n=28)
HADS Depression 38.46 57.99 48.82 7.263 0.026*
Anxiety 37.26 58.59 48.73 8.622 0.013*
BIS Body image 46.72 57.29 43.29 4.751 0.093
PDI Everyday activities 51.15 53.01 47.29 .690 0.708
Relationship with others 54.89 53.72 42.95 3.008 0.222
Total 52.50 53.21 45.82 1.223 0.543
R-DAS Dyadic consensus 47.93 49.30 56.55 1.438 0.487
Dyadic satisfaction 50.78 50.36 52.32 .085 0.958
Dyadic cohesion 51.65 47.92 55.96 1.381 0.501
Total 48.83 48.74 56.82 1.533 0.465
*p≤0.05
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A negative relationship between dyadic adjustment and
psychological morbidity and also between family coping
and psychological morbidity, both in patients and partners,
was found. These results emphasize how patients and
partners are affected by chronic disease [57], and support
previous studies of Basra and Finlay [58] and Eghlileb et al.
[59].
The positive correlation between patients’ and partners’
levels of anxiety and depression is intuitively reasonable.
Difficulties in body image, shifts in the social network and
decreased sexual intimacy as a result of psoriasis can be
triggers for chronic stress, threatening patients’ and part-
ners’ well-being as well as relationships with others [30].
As a result, it is not surprising that partners’ dyadic
adjustment was negatively associated with psychological
morbidity in patients. These findings suggest the impor-
tance of couples’ relationships to patients’ psychological
adjustment to medical conditions [60, 61].
Anxiety was inversely related to family coping, and
dyadic adjustment was positively related to family coping.
According to Rosenstrauch [62], these results may be the
result of an intentional protective buffering strategy to
exclude the partner from worries and concerns. The
protective buffering strategy may explain the results
regarding anxiety but does not explain the results regarding
depression. Not as intuitive, however, was the finding that
depression in patients was not correlated with family
coping in partners. Perhaps partners expect depression to
be part of the patients’ condition and therefore are less
affected by it. Furthermore, patients were moderately
depressed, and perhaps family coping strategies are
strongly associated with severe depression. These results
are in accordance with Duarte [64], found lupus patients
with greater disease activity to present with more anxiety
symptoms, higher levels of fatigue, more dissatisfaction
with their body image, worse quality of life and less
utilization of family coping strategies. Finally, partners’
active engagement or coping strategies, including construc-
tive problem solving, were associated with better dyadic
adjustment [61–63]. Duarte and Pereira [64] also found
better dyadic adjustment (cohesion) to be associated to the
use of more family coping strategies, albeit in patients with
SLE.
Quality of life in patients and psychological morbidity in
partners were inversely associated. Patients with lower
levels of quality of life had partners with higher levels of
Psoriatic patients
Partners HADS (depression) HADS (anxiety) R-DAS F-COPES
BDI 0.376** 0.384** −0.562*** −0.358**
0.001 0.001 0.000 0.001
STAI (state) 0.300** 0.360** −0.563*** −0.290*
0.008 0.001 0.000 0.010
STAI (trait) 0.353** 0.424*** −0.587*** −0.328**
0.002 0.000 0.000 0.003
R-DAS −0.292* −0.245* 0.838*** 0.392***
0.010 0.031 0.000 0.000
F-COPES −0.195 −0.248* 0.438*** 0.434***
0.086 0.029 0.000 0.000
Table 4 Results of Pearson cor-
relations among dyadic adjust-
ment, psychological morbidity
and family coping in patients
and partners (N=78)
*p≤0.05;**p≤0.01; ***p≤
0.001
Socio-demographic/clinical variables Psychological variables
Patient variables β p β p
1 Sex −0.020 0.842 −0.028 0.765
Age of onset 0.077 0.451 0.150 0.128
Illness severity perception −0.168 0.102 −0.061 0.534
2 Depression (HADS) 0.033 0.777
Anxiety (HADS) −0.187 0.123
Body image (BIS) −0.055 0.665
Dyadic adjustment (R-DAS) 0.289 0.012*
R2 change 0.030 0.163
Table 3 Predictors of family
coping in patients using a linear
regression (stepwise method;
N=78)
R2 =0.193; adjusted R2 =0.132
*p≤0.05
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depression and anxiety. This was especially true regarding
the two dimensions “relationship with others” and “every-
day activities”. These results show how the burden of
psoriasis may extend far beyond the physical symptoms
experienced by the patient. Psoriasis influences many
different spheres of a patient’s life, and consequently, the
effects on a patient’s social and mental health may be
dramatic. As a result, routine activities and social contacts
may often be compromised, increasing partners’ morbidity.
Therefore, quality of life of partners and relatives of
psoriatic patients may be significantly affected [59].
Another explanation for these results may have to do with
caregiver burden that may mediate the relationship between
psychological morbidity and quality of life [66]. Future
research should analyse this hypothesis and assess other
stressors in the couple’s life that may be responsible for the
exacerbation of clinical conditions in patients that impact
partners’ morbidity as well.
As stated earlier, partners who show unconditional
acceptance, demonstrate respect and sensitivity and make
their partner feel valued and attractive have a powerful
effect on patients’ dyadic adjustment [32]. Not surprisingly,
patients’ dyadic adjustment predicted partners’ dyadic
adjustment. Such results may be due to a re-evaluation
and a change of perspective on what is important, like
placing less emphasis on appearance [67]. In fact, it is
important that patients accept their skin’s appearance with the
accompanying scaliness, the localization of the injuries or
pain in order to increase sexual intimacy, decrease emotional
tension and raise dyadic adjustment [23, 29]. As a result, it
comes as no surprise that dyadic adjustment predicts family
coping in patients. Thus, to prevent the typical feelings of
frustration, anger and irritation [23], a dramatic evaluation of
body image may be necessary. Rolland [31] observed that a
communication style characterized by acceptance is essential
during a time when partners provide a basic and, perhaps, the
only source of interpersonal support. The onset of psoriasis
presents a challenge for couples to reorganize and funda-
mentally change the nature of their relationship [30]. Finally,
partners’ trait anxiety also predicted dyadic adjustment in
partners. This finding is in accordance with previous studies
that found anxiety to be negatively correlated with dyadic
adjustment [68, 69].
Conclusion
The results of this study highlight the importance of
incorporating family variables in psychosocial interventions
for psoriatic patients. According to the results, interventions
must focus on the dramatic shift in the couple’s relation-
ship, which may entail new roles and demands. This study
provides evidence that psychosocial interventions should
focus both on patients and the family system. Because
partners’ morbidity is associated with levels of patients’
morbidity and quality of life, in order to increase both
patient and partner quality of life, couples’ counselling and
therapy appear to be key components of any holistic
Patient variables Partner variables
Variables β p β p
1 Patients Depression (HADS) 0.004 0.960 0.009 0.914
Anxiety (HADS) 0.017 0.858 0.087 0.357
Body image (BIS) −0.005 0.964 0.014 0.880
Dyadic adjustment (R-DAS) 0.792 0.000** 0.651 0.000**
2 Partners Depression (BDI) 0.070 0.558
Anxiety (state) (STAI) 0.088 0.574
Anxiety (trait) (STAI) −0.373 0.037*
Family coping (F-COPES) 0.150 0.053
R2 change 2.944 3.684
Table 6 Predictors of dyadic
adjustment in partners using a
linear regression (stepwise
method; N=78)
R2 =0.617; adjusted R2 =0.685
*p≤0.05; **p≤0.001
Table 5 Results of Pearson correlations between quality of life in
patients and psychological morbidity in partners (N=78)
Patients
Partners PDI everyday
activities
PDI relationship
with others
Global
PDI
BDI 0.256* 0.236* 0.290**
0.024 0.038 0.010
STAI (state) 0.224* 0.258* 0.291**
0.048 0.023 0.010
STAI (trait) 0.281* 0.272* 0.329**
0.013 0.016 0.003
*p≤0.05; **p≤0.01
Int.J. Behav. Med.
medical care in psoriasis [70]. Past standards of care only
emphasized psoriatic patients and not their partners, and
according to results, there should be an expanded standard
of care in psoriasis among care providers.
Future studies should address the impact of psoriasis on
the couple’s developmental phase, patients’ and partners’
illness representations, caregiver burden and how all these
variables are related to dyadic adjustment and quality of life
in both patients and partners. Finally, research should also
explore the impact of sexual intimacy on patients’ and
partners’ coping strategies [71].
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